Pacira BioSciences (PCRX) Interest Coverage Ratio Growth (3y) (2013 - 2026)
Pacira BioSciences (PCRX) Interest Coverage Ratio Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 17.14% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 0.23% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -28.01% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -32.31% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 26.99% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 41.72% |
| 10 | Pacira BioSciences | 1.05 Bn | 846.97 Mn | 140.96 Mn | 39.03% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 39.03% |
| Dec 31, 2025 | 30.31% |
| Sep 30, 2025 | -62.82% |
| Jun 30, 2025 | -65.81% |
| Mar 31, 2025 | -72.65% |
| Dec 31, 2024 | 252.90% |
| Sep 30, 2024 | -36.94% |
| Jun 30, 2024 | -53.69% |
| Mar 31, 2024 | -56.43% |
| Dec 31, 2023 | 66.46% |
| Sep 30, 2023 | 27.37% |
| Jun 30, 2023 | 114.55% |
| Mar 31, 2023 | -27.28% |
| Dec 31, 2022 | -203.11% |
| Sep 30, 2022 | 74.54% |
| Jun 30, 2022 | 57.95% |
| Mar 31, 2022 | 109.13% |
| Dec 31, 2021 | -57.99% |
| Sep 30, 2021 | 81.45% |
| Jun 30, 2021 | 59.97% |